Archiv für chirurgische Onkologie

Predictive, Precise, Personalized and Prognostic Medicine for NAFDL, NASH and Liver Cancers in Sub-Saharan Africa: Challenges, Solutions and Perspectives

Abstract

Benjamin LONGO MBENZA

Background: Five P Medicine (Predictive, Personalized, Preventive, Participating, and Precise, Evidence-Based) for the Management of NAFDL, NASH, Fibrosis,
Compensated Cirrhosis, Liver Cancer, HCC Risk and Prognosis, is well established in Rich Western Countries. However, Innovations and Artificial Intelligence
such as Glycomics, Genomics, Molecular biology are lacking in Democratic Republic of the Congo (DRC).

Abstract: Thus, this lecture of the Art reports the natural history, the pathogenesis, and the prognostic value of Metabolic Hepatic Steatosis (NAFDL and NASH) for
Subclinical Hypothyroidism with Insulin Resistances, Metabolic Syndrome, Ischemic Atherosclerosis, Type 2 Diabetes Mellitus, and HCC Complex Liver diseases
(CLD) among Central Africans in Kinshasa from 2000 to 2018.